There’s always something fascinating going on in the world of baseball—and there’s always something new. Every Friday morning ...

Francisco Lindor showed signs of progressing Friday, but it came after the Mets star received a facet shot for his lingering back issue a day earlier. A facet shot is an injection of a mixture of ...

NEW YORK — Francisco Lindor is willing to do whatever it takes to get on the field during the Mets' push toward a potential postseason berth. After missing the opening series of the Mets ...

However, there is some uncertainty surrounding their superstar MVP candidate shortstop Francisco Lindor, who remains out with a back injury. The good news is that Lindor's MRI on Monday revealed ...

The Mets’ playoff push will be without Francisco Lindor for a fourth straight day. Lindor will not be in the lineup Thursday against the Phillies due to his back issue as the Mets kick off a ...

NEW YORK -- Shortstop Francisco Lindor said he "should be back" before the regular season ends after an MRI exam on his lower back Monday revealed no structural damage, a huge relief for a New ...

Mets shortstop Francisco Lindor remained out of the lineup for Friday night's game, but there continues to be optimism surrounding his return to the lineup after he had an injection on Thursday.

That’s when the Mets put up five runs on four hits, including a Francisco Alvarez home run, his fourth in eight games, three walks, and a hit batsman.

Carlos Mendoza’s reaction to the relatively positive MRI report on Francisco Lindor’s back injury told you just how worried the Mets were that their star shortstop might be out for the season.

Francisco Lindor was taken out of Sunday's game against the Philadelphia Phillies due to lower back tightness. The New York Mets were hoping for the best news with an MRI scheduled. On Monday ...

The New York Mets' crucial walk-off loss to the Philadelphia Phillies on Sunday was bad enough for the club, and the ongoing back troubles of star shortstop Francisco Lindor made matters worse.